MoneyWorks4Me

Abbott India informs about trading window closure

19 Dec 2025 Evaluate

Abbott India has informed that in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the Shares of the Company by the Designated Persons and their immediate relatives shall be closed from Thursday, January 1, 2026 and the same shall reopen after 48 hours from the declaration of the Unaudited Financial Results of the Company for the quarter ending on December 31, 2025.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..